Skip to content
Clinical Trials – home

Respiratory tract infection Diagnostics

3 / 5 trials open to patients8 countries

In short

Diagnosing a respiratory tract infection involves understanding your symptoms, knowing when to seek medical help, and undergoing appropriate tests to determine whether the cause is viral or bacterial. While most infections clear up on their own, proper diagnosis helps identify those that need specific treatment and ensures people at higher risk receive timely care.

Key points

  • Most respiratory infections can be diagnosed based on symptoms and physical examination alone, without requiring extensive testing.
  • Healthcare providers usually diagnose upper respiratory infections based on your symptoms and examination findings, reserving testing for severe cases or high-risk individuals.
  • Nasal swabs and throat cultures help identify specific viruses or bacteria when knowing the exact cause will change treatment decisions.
  • People over 65, pregnant women, those with chronic health conditions, or individuals with weakened immune systems should seek medical evaluation promptly when respiratory symptoms develop.
  • Imaging tests like chest X-rays are typically reserved for cases where doctors suspect pneumonia or other complications.
  • Clinical trials use more rigorous diagnostic criteria than routine clinical practice, often requiring laboratory confirmation of infections.
  • Warning signs that require immediate medical attention include severe breathing difficulty, coughing up blood, high fever lasting more than three days, or symptoms that worsen after initial improvement.
  • Lower respiratory infections are the leading cause of death among all infectious diseases globally, making timely diagnosis and treatment crucial for vulnerable populations.

Introduction: Who Should Seek Diagnostic Testing

Respiratory tract infections are among the most common reasons people visit their primary care doctor. These infections affect the parts of your body involved in breathing, including your nose, sinuses, throat, airways, and lungs. While many of these infections resolve without medical intervention, certain people should seek diagnostic testing to ensure proper care and prevent complications.

You should consider seeking medical evaluation if you have symptoms of a respiratory infection and fall into certain categories. People over the age of 65 are at higher risk for complications and should consult their healthcare provider when symptoms develop. Similarly, pregnant women should seek medical advice, as respiratory infections can affect both mother and baby. If you have a weakened immune system—for example, because you have diabetes or are undergoing chemotherapy—getting a proper diagnosis becomes especially important.

Those with long-term health conditions such as heart disease, lung problems, or kidney conditions should also pursue diagnostic testing when respiratory symptoms appear. Your existing health challenges can make even common infections more dangerous. Additionally, if you have been coughing for more than three weeks, have a high temperature lasting more than three days, or are coughing up blood or bloodstained mucus, these are clear signals that medical evaluation is necessary.

Even if you don't fall into these high-risk groups, you should see a healthcare provider if you feel very unwell or if your symptoms are getting worse rather than better. Sometimes what starts as a simple cold can develop into a more serious condition like pneumonia, which requires different treatment approaches.

Classic Diagnostic Methods for Identifying Respiratory Infections

Healthcare providers rely on several diagnostic approaches to identify respiratory tract infections and distinguish them from other conditions. The diagnostic process typically begins with a thorough evaluation of your medical history and symptoms, followed by a physical examination. This initial assessment helps doctors determine whether additional testing is necessary and what type of tests would be most helpful.

Clinical Assessment Based on Symptoms

In many cases, healthcare providers can diagnose upper respiratory infections based primarily on your symptoms and a physical examination. During your visit, your doctor will ask about the nature of your symptoms: when they started, how severe they are, and whether they're improving or worsening. They'll perform a physical examination that may include listening to your lungs with a stethoscope, which is an instrument that amplifies sounds from inside your body, checking your throat, and feeling lymph nodes in your neck for swelling.

This symptom-based approach works well for most upper respiratory infections because they share common features: runny or stuffy nose, sore throat, cough, headache, and sometimes fever. Your doctor can often tell from this assessment whether you have a viral infection that will resolve on its own or whether further testing is needed to rule out bacterial infection.

Nasal Swabs and Throat Cultures

When your healthcare provider needs to determine the specific cause of your infection, they may perform a nasal swab or throat culture. A nasal swab involves gently inserting a long, flexible cotton swab into your nostril to collect a sample of mucus and cells. This sample is then tested in a laboratory to identify specific viruses or bacteria causing your symptoms.

Throat cultures work similarly. Your doctor uses a swab to collect cells from the back of your throat. This test is particularly useful for identifying bacterial infections like strep throat, which requires antibiotic treatment. Some rapid tests can provide results within minutes, while other cultures may take a day or two to grow in the laboratory before identification is possible.

These swab tests are generally painless, though they may cause brief discomfort or trigger a gag reflex when collecting throat samples. The information they provide helps doctors determine whether antibiotics are necessary or whether your body can fight off the infection without medication.

Sputum Testing

For lower respiratory infections that affect the airways and lungs, your healthcare provider may request a sputum sample. Sputum is the mucus or phlegm that you cough up from deep in your lungs. This is different from saliva, which comes from your mouth. A sputum sample can reveal what type of bacteria, virus, or even fungi might be causing your infection.

To collect a sputum sample, you'll be asked to cough deeply and spit the material into a special container. Sometimes this happens naturally when you have a productive cough. Other times, healthcare providers may use a technique called sputum induction, where you breathe in a mist that helps loosen mucus, making it easier to cough up. Laboratory technicians then examine the sputum under a microscope and may culture it to identify the specific organism causing your illness.

Blood Tests

Blood tests can provide valuable information about respiratory infections, particularly when doctors need to assess how your body is responding to the infection or rule out other conditions. These tests might measure your white blood cell count, which typically increases when your body is fighting an infection. The specific pattern of white blood cells can sometimes suggest whether an infection is viral or bacterial.

In some cases, blood tests can detect antibodies—proteins your immune system produces in response to specific infections. An antibody test can show whether you've been exposed to a particular virus or bacteria, even if you're no longer actively infected. This information can be useful for understanding your immune status and whether you might have protection against future infections.

Imaging Studies

When healthcare providers suspect a lower respiratory infection or complications from an upper respiratory infection, they may order imaging tests. A chest X-ray is the most common imaging test for respiratory infections. This painless procedure uses small amounts of radiation to create pictures of your lungs and chest. X-rays can reveal pneumonia, fluid around the lungs, or other abnormalities that suggest serious infection.

For more complex cases, doctors might order a computed tomography or CT scan, which provides more detailed images than a standard X-ray. CT scans can show the sinuses, airways, and lung tissue in greater detail, helping identify infections that might not be visible on regular X-rays. However, these more advanced imaging tests are typically reserved for severe cases or when initial treatments haven't worked as expected.

Pulmonary Function Testing

In certain situations, particularly when respiratory infections are recurrent or chronic, healthcare providers may recommend pulmonary function testing. These tests measure how well your lungs work by assessing how much air you can breathe in and out, and how quickly you can exhale. While not typically used for diagnosing acute infections, these tests help evaluate whether an infection has affected your lung capacity or whether underlying lung conditions might be making you more susceptible to respiratory infections.

Diagnostics for Clinical Trial Qualification

Clinical trials investigating treatments for respiratory tract infections use specific diagnostic criteria to ensure participants truly have the condition being studied. These criteria are often more rigorous than what's used in routine clinical practice, as researchers need to be certain about diagnoses to accurately evaluate whether new treatments work.

Standard Testing Protocols

Clinical trials for respiratory infections typically require confirmed diagnoses through laboratory testing rather than relying solely on clinical symptoms. For studies involving viral infections, participants usually must provide positive results from molecular tests such as nucleic acid amplification tests, which detect genetic material from specific viruses. These tests are highly sensitive and can identify viruses even when present in small amounts.

For bacterial infection trials, confirmed bacterial cultures from appropriate samples—such as sputum, throat swabs, or nasal specimens—are generally required. These cultures must show growth of the specific bacteria being studied. Some trials may also require information about antibiotic resistance patterns to ensure participants receive treatments that have a chance of working against their particular infection.

Rapid Testing in Research Settings

Many clinical trials now incorporate rapid diagnostic tests that can provide results quickly, allowing for faster enrollment and treatment initiation. Rapid viral tests, for example, can detect common respiratory viruses like influenza, respiratory syncytial virus (RSV), and COVID-19 within minutes to hours. These tests help researchers identify eligible participants promptly, which is particularly important for studies of acute infections where early treatment may be most beneficial.

The use of rapid antigen tests in clinical trials has grown significantly. These tests detect specific proteins from viruses or bacteria and offer the advantage of providing quick results without requiring complex laboratory equipment. However, trials often confirm rapid test results with more sensitive laboratory-based methods to ensure diagnostic accuracy.

Baseline Health Assessments

Before enrolling in a clinical trial for respiratory infections, potential participants undergo comprehensive health assessments. These baseline evaluations help researchers understand each person's overall health status and identify any conditions that might affect their response to the treatment being studied or put them at risk for complications.

Baseline assessments typically include detailed medical history, physical examination, vital signs measurement (such as temperature, blood pressure, and respiratory rate), and often blood tests to check overall organ function. For trials involving medications, liver and kidney function tests are particularly important because these organs process most drugs. Chest X-rays or other imaging may be performed to document the extent of infection before treatment begins.

Monitoring Tests During Trials

Clinical trials for respiratory infections don't stop at diagnosis. Throughout the study period, participants undergo regular monitoring to track how their infection responds to treatment and to detect any side effects from the therapy being tested. This monitoring typically includes repeat testing to see if the virus or bacteria has been eliminated, symptom assessments to determine if participants feel better, and safety monitoring through blood tests and physical examinations.

The frequency and type of monitoring tests vary depending on the specific trial, but most studies of acute respiratory infections involve follow-up testing at regular intervals—perhaps at days three, five, seven, and fourteen after starting treatment. These repeated measurements help researchers understand not just whether a treatment works, but how quickly it works and how long its effects last.

Prognosis and Survival Rate

Prognosis

The outlook for people with respiratory tract infections varies depending on several factors, including the type of infection, the person's overall health, and how quickly treatment begins if needed. Most upper respiratory infections, such as the common cold, have an excellent prognosis. These viral infections typically resolve on their own within one to two weeks, with symptoms gradually improving as the immune system clears the virus.

Lower respiratory infections such as pneumonia tend to be more serious than upper respiratory infections. However, with appropriate treatment, most people recover fully from pneumonia as well. The recovery timeline for lower respiratory infections is often longer, potentially taking several weeks before full strength and energy return.

Certain groups face higher risks for complications and poorer outcomes. People over age 65, those with chronic health conditions like heart disease or diabetes, individuals with weakened immune systems, and newborns are more vulnerable to severe illness from respiratory infections. These individuals are at greater risk for complications such as respiratory failure, sepsis (a life-threatening response to infection), or organ damage if bacterial or fungal infections spread beyond the respiratory system.

Upper respiratory infections rarely lead to serious complications in otherwise healthy individuals. However, when complications do occur, they can include the infection spreading to the lungs and causing pneumonia. Untreated bacterial infections can potentially lead to more severe conditions including meningitis (infection of the membranes around the brain and spinal cord), rheumatic fever, or sepsis.

Survival rate

Lower respiratory infections remain the leading cause of death among all infectious diseases globally, highlighting their potential severity despite effective treatments being available. However, specific survival statistics vary widely based on the type of infection, the individual's health status, and access to timely medical care.

The vast majority of people with upper respiratory infections recover completely without any lasting effects. These infections, while uncomfortable, are rarely life-threatening in healthy individuals. Lower respiratory infections like pneumonia have more variable outcomes. With appropriate treatment, most previously healthy people recover from pneumonia, though those with significant underlying health problems face higher risks.

Each year, respiratory virus illnesses result in significant healthcare burden. Recent estimates suggest that respiratory viruses cause at least one million hospitalizations and more than 70,000 deaths annually in the United States alone. These numbers emphasize the importance of preventive measures, early diagnosis, and appropriate treatment, particularly for vulnerable populations.

Did you know?

  1. Diagnostic tests influence approximately 70% of all healthcare decisions, yet only 3 to 5% of healthcare budgets are spent on diagnostic services, making them one of the most cost-effective tools in medicine.[25]
  2. While there are hundreds of different viruses that can cause the common cold, doctors rarely test to identify the specific virus because the treatment approach remains the same regardless of which cold virus you have.[2]
  3. Researchers have developed breath tests that can quickly diagnose lung infections by analyzing the chemical compounds in exhaled air, potentially offering a non-invasive alternative to traditional testing methods.[3]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Respiratory tract infection

Recruiting trials first

See all 5 trials →
Quick filters

5 clinical trials in this condition

Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:HYPOCHLOROUS ACID
  • Sponsor:Softox Solutions AS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mercaptamine
  • Sponsor:National Institute For Infectious Diseases Lazzaro Spallanzani
Countries:ItalyItaly
  • Participants:65+ years
  • Sponsor:Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nitric Oxide
  • Sponsor:Universitair Medisch Centrum Utrecht
See all 5 trials →filters applied: condition = Respiratory tract infection

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).